Seer (SEER) to Present at Two Major Healthcare Investment Conferences in November

0
Seer (SEER) to Present at Two Major Healthcare Investment Conferences in November




Seer (Nasdaq: SEER) has announced its participation in two upcoming investor conferences in November. The company will participate in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference in Boston on November 11th at 11:30 a.m. ET, and at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on November 21st at 10:00 a.m. ET.

Both sessions will be available via live webcast on the Investor section of Seer’s website at investor.seer.bio, with archived replays accessible after the events.

Seer (Nasdaq: SEER) ha annunciato la sua partecipazione a due prossime conferenze per investitori a novembre. L’azienda parteciperà a una chiacchierata informale durante il Guggenheim Inaugural Healthcare Innovation Conference a Boston l’11 novembre alle 11:30 ET, e al Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum a New York il 21 novembre alle 10:00 ET.

Entrambi i sessioni saranno disponibili tramite webcast dal vivo nella sezione Investitori del sito web di Seer all’indirizzo investor.seer.bio, con registrazioni archiviate accessibili dopo gli eventi.

Seer (Nasdaq: SEER) ha anunciado su participación en dos conferencias para inversores que se llevarán a cabo en noviembre. La compañía participará en un chat informal en la Guggenheim Inaugural Healthcare Innovation Conference en Boston el 11 de noviembre a las 11:30 a.m. ET, y en el Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum en Nueva York el 21 de noviembre a las 10:00 a.m. ET.

Ambas sesiones estarán disponibles a través de webcast en vivo en la sección para Inversores del sitio web de Seer en investor.seer.bio, con repeticiones archivadas accesibles después de los eventos.

Seer (Nasdaq: SEER)는 11월에 있을 두 개의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 11월 11일 오전 11:30 ET에 보스턴에서 열리는 Guggenheim Inaugural Healthcare Innovation Conference의 파이어사이드 채팅에 참여하고, 11월 21일 오전 10:00 ET에 뉴욕에서 열리는 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum에 참석합니다.

두 세션 모두 Seer 웹사이트의 투자자 섹션인 investor.seer.bio에서 실시간 웹캐스트로 제공되며, 이벤트 후에는 아카이브된 재생도 접근할 수 있습니다.

Seer (Nasdaq: SEER) a annoncé sa participation à deux conférences pour investisseurs à venir en novembre. L’entreprise participera à une discussion informelle lors de la Guggenheim Inaugural Healthcare Innovation Conference à Boston le 11 novembre à 11h30 ET, et au Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum à New York le 21 novembre à 10h00 ET.

Les deux sessions seront disponibles en direct via un webcast sur la section Investisseurs du site web de Seer à l’adresse investor.seer.bio, avec des rediffusions archivées accessibles après les événements.

Seer (Nasdaq: SEER) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im November bekannt gegeben. Das Unternehmen wird an einem Fireside-Chat auf der Guggenheim Inaugural Healthcare Innovation Conference in Boston am 11. November um 11:30 Uhr ET teilnehmen und beim Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York am 21. November um 10:00 Uhr ET.

Beide Sitzungen werden über einen Live-Webcast im Investorenbereich der Seer-Website unter investor.seer.bio verfügbar sein, mit nachträglich zugänglichen Aufzeichnungen nach den Veranstaltungen.











REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor conferences:

  • Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA
    Fireside chat on Monday, November 11th at 11:30 a.m. Eastern Time
  • Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NY
    Fireside chat on Thursday, November 21st at 10:00 a.m. Eastern Time

Live webcasts of the sessions will be available on the Investor section of Seer’s website at investor.seer.bio. Archived replays will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Media Contact:
Patrick Schmidt
[email protected]

Investor Contact:
Carrie Mendivil
[email protected]









FAQ



When is Seer (SEER) presenting at the Guggenheim Healthcare Conference in November 2024?


Seer will present at the Guggenheim Inaugural Healthcare Innovation Conference on Monday, November 11th, 2024, at 11:30 a.m. Eastern Time in Boston.


What investor conferences is Seer (SEER) attending in November 2024?


Seer is attending two conferences: the Guggenheim Inaugural Healthcare Innovation Conference in Boston and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York.


Where can I watch Seer’s (SEER) November 2024 investor conference presentations?


Live webcasts of Seer’s presentations will be available on the Investor section of their website at investor.seer.bio, with archived replays available after the events.


What time is Seer’s (SEER) presentation at the Canaccord Genuity Forum?


Seer will present at the Canaccord Genuity Forum on Thursday, November 21st, 2024, at 10:00 a.m. Eastern Time.





link

Leave a Reply

Your email address will not be published. Required fields are marked *